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Left ventricular thrombus complicating myocardial in-
farction was diagnosed by two-dimensional echocardi-
ography in 119 patients. The infarct site was anterior in
98 patients and inferior in 11. Systemic embolism oc-
curred in 26 patients (stroke in 18, lower limb embolism
in 7 and mesenteric embolism in I). A protruding con-
figuration of the thrombus was more common in the
patients with embolism than in those without (23 [88%J
of 26 versus 17 [18%] of 93) (p < 0.01). Free mobility
of the thrombus was found in 15 (58%) of 26 and 3 (3%)
of 93 casts, respectively (p < 0.01). In predicting em-
bolism, protruding thrombus configuration had a sen-
sitivity of 88% and a specificity of 82%, and positive
and negative predictive accuracy was 57 and 96%, re-
spectively. For free mobility of the thrombus, sensitivity
was 58%, specificity 97%, positive predictive accuracy
85% and negative predictive accuracy 89%.
Autopsy findings have shown that left ventricular thrombus
is a common complication after acute myocardial infarction
(1-5). With the advent of two-dimensional echocardiog-
raphy, the diagnosis of left ventricular thrombosis can be
made in vivo with good sensitivity and specificity (6-8),
and much has been learned about the incidence and natural
history of left ventricular thrombus in patients surviving the
acute episode (9-11). It has become clear that left ventric-
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In the 46 patients whose echocardiogram was ob-
tained during the hospital admission for the index in-
farct, repeat echocardiograms were obtained diJring oral
anticoagulant therapy. Twelve of these 46 patients had
embolism and 2 of the 12died. In seven of these patients,
full dose oral anticoagulant therapy had been given be-
fore embolism occurred and in five it was started after
an embolic event. The thrombus decreased in size or
disappeared in six patients; in four the thrombus showed
no change, and in two of these four emboli recurred
despite anticoagulation.
It is concluded that two-dimensional echecardieg-
raphy may help delineate the embolic potential of left
ventricular thrombus complicating myocardial infarc-
tion and may be of value in weighing the benefits and
disadvantages of oral anticoagulant therapy.
(J Am CoU Cardiol 1985:1276-80)
ular thrombus is unusual in patients with art inferior infarct,
but common in patients with an anterior infarct, especially
in the presence of severe wall motion abnormalities. In the
latter group, the incidence of left ventricular thrombus is
approximately 30% (9-11).
However, clinically recognized systemic embolism oc-
curs in only a small number of patients with infarction. In
three major studies (12-14), the incidence of systemic em-
bolism was low, but a beneficial effect of oral anticoagulant
treatment was demonstrated. However, anticoagulation may
not be feasible in some patients and may be contraindicated
in others. If some echocardiographic features of left ven-
tricular thrombi could identify those most likely to ernbolize,
this would be of help in selecting patients most likely to
benefit from anticoagulant treatment.
A few preliminary reports (15-17) suggested that free
mobility or a protruding structure of the thrombus might be
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value of two-dimensional echocardiography for delineating
the embolic potential of left ventricular thrombus in more
than 1()() patients.
Methods
Patients. The clinical course of 119 patients at our two
cardiology centers with a two-dimensional echocardio-
graphic diagnosis of left ventricular thrombus complicating
myocardial infarction was reviewed. All patients were stud-
ied during the period from January 1, 1981 to May I, 1983.
At both institutions ATL Mark 300 and Toshiba SSH lOA
and SSH 40 two-dimensional echocardiographic equipment
was used .
Diagnostic criteria. Left ventricular thrombus was de-
fined as an echo-dense mass within the left ventricular cavity
1) that was adjacent to asynergic myocardium, 2) that could
be distinguished from the endocardium, and 3) that could be
visualized in more than one echocardiographic view , pref-
erably from different transducer positions . To this end we
used all available acoustic windows . All tape recordings
were independently reviewed by two investigators in real
time and slow motion in a blinded fashion. In case of dis-
crepancies a consensus was reached.
The thrombus was described as protruding if the throm-
bus-blood interface showed a curvature that was opposite
in sign to the curvature of the adjacent left ventricular wall.
In other words , if the free margin of the thrombus was
concave (and thus following the curvature of the left ven-
tricular wall) it was considered to be nonprotruding (Fig . I) .
A thrombus was considered freely mobile if the luminal
side of the thrombus showed motion independent of that of
the adjacent wall , sometimes opposite in direction , some-
times truly erratic . Motion of the thrombus following the
wall in dyskinetic areas was therefore not considered free
mobility (Fig. 2).
Myocardial infarction was diagnosed by a typical his-
tory , development of diagnostic Q waves and a typical rise
and fall in creatine kinase-MB isoenzyme. Infarct localiza-
tion was defined by the criteria of the American Heart As-
sociat ion (18) . Anterior, septal and lateral infarcts were
grouped as anterior wall infarcts , and, likewise, inferior and
posterior infarcts were grouped together as inferior infarcts .
Patients with an infarct in whom thrombus was diagnosed
during the period of hospital stay «4weeks) were grouped
as having an acute infarction . All patients with an acute
infarction were studied prospectively as part of an ongoing
study in the coronary care unit. Patients with infarction in
whom thrombus was diagnosed after this 4 week period
were considered to have chronic infarction. This part of the
study was essentially retrospective.
Statistical analysis. Comparisons between subgroups
were performed by Student's t test or chi-square testing
where appropriate . A probability value of less than 0.05
was considered statistically significant. Sensitivity of a di-
agnostic criterion was defined as: TP/TP + FN and spec -
ificity as: TNffN + FP, where FN = false negative,
FP = false positive, TN = true negative and TP = true
positive results. Positive predictive accuracy was calculated
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Figure 2. Same case as in Figure lA, Two still-frames from
different time periods in the cardiac cycle illustrating the free
mobility of this thrombus (arrows). In real time, this thrombus
showed erratic motion. Abbreviations as in Figure I.
Figure 1. Two-dimensional echocardiograms . A, Example of a
protruding type of left ventricular thrombus (arrowheads) in an
apical two chamber view (Ap2C) from the cardiac apex. B, Ex-
ample of a nonprotruding thrombus (arrowheads) in an apical four
chamber view (Ap4C). The thrombus is concave toward the left
ventricular lumen. LA = left atrium; LV = left ventricle; RA =
right atrium; RV = right ventricle.
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Figure 3. Flow chart showing number of patients with thrombus
characteristics in relation to embolization. LVT = left ventricular
thrombus; MI = myocardial infarction; SE = systemic embolism.
Results
Of the 119 patients, 46 had acute myocardial infarction.
The remaining 73 patients had chronic infarction and were
studied 4 to 25 months after infarction. The infarct site was
anterior in 108 patients and inferior in 11. Clinically rec-
ognized peripheral embolism occurred in 26 patients (21%)
of the study group including stroke in 18, lower limb em-
bolism in 7 and mesenteric embolism in 1. Although em-
bolism occurred more frequently in the patients with an acute
infarct than in those with a chronic infarct, this difference
was not significant: 12 (26%) of 46 versus 14 (19%) of 73
(p = 0.26).
Thrombus characteristics. A protruding type of em-
bolus was seen in 23 (88%) of 26 of the patients with
embolism and in 17 (18%) of 93 of those without (Fig. 3);
this difference is significant (p < 0.01). Free mobility of
the thrombus was seen in 15 (58%) of 26 patients in the
embolism group compared with 3 (3%) of 93 in the nonem-
bolism group (p < 0.01). In all patients with a freely mobile
thrombus, the thrombus was also protruding. Eight of the
patients in the embolism group had a protruding thrombus
without free mobility and the same was true in 14 patients
of the nonembolism group. In no case was free mobility
observed in a nonprotruding thrombus (Fig. 3). Localization
of the thrombus was apical in all but two patients with
thrombus in a basal posterior wall aneurysm.
Figure 4. Decision tree for assessing indications and contrain-
dications of oral anticoagulation (OAC) if left ventricular thrombus
(LVT) has been diagnosed by two-dimensional echocardiography
(2DE).
Sensitivity/specificity analysis of protruding thrombus
configu~ation and of free thrombus mobility in identifying
thrombi prone to embolization indicated that a protruding
~hrombus ~onfiguration had a greater sensitivity in predict-
mg systermc embolization than did free mobility (23 [88%]
of 26 versus 15 [58%] of 26), but was less specific (76
[82%] of 93 versus 90 [97%] of 93). Positive predictive
accuracy of a protruding configuration was 23 (57%) of 40
and negative predictive accuracy was 76 (96%) of 79. Pos-
itive and negative predictive accuracy of free mobility was
15 (85%) of 18 and 90 (89%) of 101, respectively.
Role of anticoagulant therapy. The effects of oral an-
ticoagulants were investigated in the 46 patients with throm-
bus complicating an acute infarct. Of these, two were lo-
cated in a posterior wall aneurysm; systemic embolism
occurred in neither of them. Forty-four patients had an an-
terior infarct with thrombus, and systemic embolism oc-
curred in 12. Seven of these 12 patients were already on
full dose oral anticoagulant therapy when embolism oc-
cu.rred. The remaining five were taking subcutaneous hep-
ann but changed to an oral anticoagulant after the embolic
event. Two of the 12 patients with embolism died (one
developed cardiogenic shock 2 days after sustaining emboli
~o both legs and another died from mesenteric embolism);
m both, the diagnosis of embolism and of left ventricular
thrombus were confirmed at autopsy. Repeat echocardio-
grams were obtained in the 10 survivors of embolism while
taking oral anticoagulants at 3 months. In three, the throm-
bus had disappeared, in another three it had decreased in
size and in four there was no change in thrombus size or
configuration. A new episode of systemic embolism oc-
curred in two patients despite treatment with an oral anti-
coagulant; in both patients, thrombus configuration was
unchanged.
In the 73 patients with thrombus complicating chronic
infarction, the thrombus site was anterior in 64 and inferior
in 9. Thirteen and one of these patients, respectively, had
systemic embolism. Only 4 patients were receiving an oral
anticoagulant at the time of embolism, but all 14 were treated
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onstration of a left ventricular thrombus as its likely source.
In none of the patients did a new embolic episode occur.
Follow-up echocardiograms could not be obtained system-
atically in this group.
Discussion
Left ventricular thrombus can be found frequently at au-
topsy in patients with myocardial infarction (incidence rates
of 14 to 68% have been reported) (1-5). In patients undergo-
ing open heart surgery (mainly aneurysmectomy) after myo-
cardial infarction, a high incidence of left ventricular throm-
bus also was found, ranging between 16 and l()()% of the
cases (19) (53% in the largest reported series [20D. Despite
this high incidence of thrombus, systemic embolism is rel-
atively uncommon. In three major series (12-14) it occurred
in 2.5 to 4.9% of patients not receiving anticoagulant ther-
apy and in 0.7 to 1.1% of those receiving anticoagulant
therapy. Because the consequences of an embolus are often
disastrous and because the incidence of systemic embolism
might be reduced by treatment with oral anticoagulant ther-
apy, recognition of this high-risk group is of paramount
importance.
Before the era of two-dimensional echocardiography, an
in vivo diagnosis of infarct-related thrombus could be made
in a few patients by left ventricular cineangiography. How-
ever, this procedure is performed in selected patients, is
invasive and has a low sensitivity (approximately 30%) (21).
Two-dimensional echocardiography has been shown to have
good sensitivity and specificity in the diagnosis of thrombus
(6-8). Moreover, it is a noninvasive procedure that can be
repeated as needed. Several echocardiographic studies have
indicated that thrombus is a frequent sequel to infarction,
especially anterior wall infarction with severe wall motion
abnormalities.
Thrombus prone to embolization. On the basis of
pathologic data (22) and preliminary echocardiographic re-
ports (15-17), it has been suggested that protrusion of the
thrombus into the left ventricular cavity (and thus exposure
ofthrombus to blood flow on several sides) and free mobility
of the thrombus (which may indicate friability of the throm-
bus) might entail an increased risk of embolization. Our
study supports this concept. The results showed that throm-
bus of a protruding type is far more common in patients
with embolism than in those without. Free intracavitary
mobility of the thrombus was present in more than half of
those with embolism and virtually absent in the group with-
out. In other words, a protruding thrombus carries a sub-
stantial (but not absolute) risk of systemic embolization. If
the thrombus shows free mobility, the risk is even greater.
Although the two criteria employed in the present study
may seem subjective, they can be appreciated readily: a
thrombus was considered protruding if its luminal edge had
a curvature opposite in sign to that of the adjacent left
ventricular wall. If the thrombus edge moves with the ad-
jacent wall it is not freely mobile. Free mobility is motion
unrelated to that of the wall and often erratic.
Effects of oral anticoagulant therapy. Only the pa-
tients with thrombus complicating acute infarction form a
prospective group. In patients receiving oral anticoagulant
therapy, it was possible for a thrombus to disappear or
decrease in size or to stay the same. Because our series was
small and not randomized, it is hard to draw any conclusions
from it. It is disappointing, however, that of the 12 patients
with embolism complicating thrombus in acute infarction,
7 were already receiving oral anticoagulant therapy when
embolism occurred, and that in 2, embolism recurred while
they were receiving effective oral anticoagulant therapy. In
the group with emboli complicating thrombus related to
chronic infarcts, follow-up echocardiograms could not be
obtained in a systematic fashion. Moreover, this was not a
prospective series.
Recommendations for anticoagulant therapy. If left
ventricular thrombus is diagnosed on two-dimensional echo-
cardiography, it would seem prudent to administer antico-
agulants to all patients if no contraindications exist (12-14).
If contraindications exist, the risks of anticoagulant treat-
ment should be weighed against the risks of no treatment.
It is here that the two-dimensional echocardiographic fea-
tures of the thrombus may help in decision-making (Fig.
4). Ultimately, however, the efficacy of oral anticoagulants
in preventing systemic embolism or resolving left ventric-
ular thrombus, or both, must be proved in a randomized
and possibly blinded (probably multicenter) two-dimen-
sional echocardiographic study.
Conclusions. We believe that left ventricular thrombus
complicating myocardial infarction that is prone to embol-
ization can be identified by two-dimensional echocardiog-
raphy on the basis of a protruding configuration, especially
in association with free mobility of the free edge of the
thrombus. These features may help in outlining the indi-
cations for oral anticoagulant therapy in patients with relative
contraindications for such therapy.
We thank Anke Schagen for typing the manuscript.
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